North America’s Wound Debridement Products Market Worth US$ 307.8 Million by 2024
Health risks of unattended wounds or undue exposure to infected tissues are becoming an alarming concern in the healthcare industry of North America. Ineffectiveness of conventional wound care products continues to impede the surgical improvement of patients being treated with infected diseases.
Health risks of unattended wounds or undue exposure to infected tissues are becoming an alarming concern in the healthcare industry of North America. Ineffectiveness of conventional wound care products continues to impede the surgical improvement of patients being treated with infected diseases.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Throughout the forecast period, hospitals will retain as the dominant end-users of wound<br />
debridement products in <strong>North</strong> America. By the end of <strong>2024</strong>, revenues procured from wound<br />
debridement products sales to hospitals will be nearly 50% of the gross estimated revenues.<br />
ASCs and specialized clinics are expected to collectively garner over <strong>US$</strong> 100 million in<br />
revenues <strong>by</strong> <strong>2024</strong>-end, while wound debridement products sales accounted <strong>by</strong> <strong>North</strong> American<br />
nursing facilities will expand at a moderate CAGR of 4.6%. Increasing incidences of chronic<br />
ulcers in <strong>North</strong> America is projected to instrument the growth in demand for wound debridement<br />
products in hospitals. Revenues generated from the wound debridement products sales in<br />
chronic ulcers treatment across <strong>North</strong> American hospitals are expected to expand at an<br />
impressive 8.2% CAGR over the forecast period.<br />
Download Report Table of Content, Figures, and Tables @<br />
http://www.persistencemarketresearch.com/market-research/north-america-wounddebridement-products-market/toc<br />
Leading medical devices manufacturers in the US are recognized as some of the key players<br />
participating in the growth of wound debridement products market in <strong>North</strong> America. Companies<br />
such as Smith & Nephew PLC, Zimmer Biomet Holdings, Inc., Misonix, and Lohmann &<br />
Rauscher International are known for leading the market in terms of production of effective lowfrequency<br />
ultrasound wound debridement products. Derma Sciences Inc. holds an extended<br />
product portfolio for surgical wound debridement products and mechanical debridement pads,<br />
while BSN Medical specialized in traditional wound debridement and larval therapy products.<br />
Arobella Medical LLC, DeRoyal Industries Inc., and Söring GmbH are some other key<br />
manufacturers & suppliers of wound debridement products in <strong>North</strong> America.<br />
Browse Complete Report @ http://www.persistencemarketresearch.com/checkout/12967<br />
<strong>North</strong> America <strong>Wound</strong> <strong>Debridement</strong> <strong>Products</strong> <strong>Market</strong> <strong>by</strong> <strong>2024</strong>
Change language